title: Methoxphenidine Use Disorder: First Case Notified to the French Addictovigilance Network.
authors.affiliation: Addictovigilance Center, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, Montpellier, France Addictovigilance Center, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, Montpellier, France c-eiden@chu-montpellier.fr Addictology Department, University Hospital of Nîmes, Nîmes, France Addictovigilance Center, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, Montpellier, France.
authors.forename: William
authors.initials: W
authors.lastname: Champeau
authors.forename: Céline
authors.initials: C
authors.lastname: Eiden
authors.forename: Julien
authors.initials: J
authors.lastname: Gambier
authors.forename: Hélène
authors.initials: H
authors.lastname: Peyriere
mesh_terms: D000328:Adult; D000778:Anesthetics, Dissociative / Q000009:adverse effects*; D001714:Bipolar Disorder; D015897:Comorbidity; D004335:Drug and Narcotic Control; D005602:France; D006801:Humans; D008297:Male; D010880:Piperidines / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*; D019966:Substance-Related Disorders / Q000175:diagnosis*; D055815:Young Adult
chemical_list: D000778:Anesthetics, Dissociative; D010880:Piperidines; C000595747:1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine